Legal & General Group Plc Acquires 78,807 Shares of Intuitive Surgical, Inc. $ISRG

25 May 2026, 07:40 by Jessica Moore · The Cerbat Gem

Legal & General Group Plc boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 3.3% in the fourth quarter, HoldingsChannel reports. The firm owned 2,455,521 shares of the medical equipment provider’s stock after purchasing an additional 78,807 shares during the period. Legal & General Group Plc’s holdings in Intuitive Surgical were worth $1,390,709,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in ISRG. Brighton Jones LLC increased its holdings in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares in the last quarter. Sivia Capital Partners LLC increased its holdings in Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after purchasing an additional 34 shares in the last quarter. Schnieders Capital Management LLC. increased its holdings in Intuitive Surgical by 38.0% in the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after purchasing an additional 268 shares in the last quarter. Osterweis Capital Management Inc. bought a new stake in Intuitive Surgical in the second quarter worth approximately $200,000. Finally, Main Street Financial Solutions LLC increased its holdings in Intuitive Surgical by 92.4% in the second quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock worth $1,592,000 after purchasing an additional 1,407 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Intuitive unveiled more than 100 upcoming upgrades for its da Vinci 5 robotic surgery system, including improved force-feedback tools, telecollaboration features, and security/reliability enhancements, which could strengthen the company’s competitive moat and support future procedure growth. Intuitive Surgical’s Da Vinci 5 Upgrades Aim To Deepen Moat For Investors
Positive Sentiment: Intuitive also announced innovations tied to its “Quintuple Aim” strategy, reinforcing product development momentum and the company’s push to improve surgeon autonomy and operating-room efficiency. Intuitive Announces Innovations to Advance Quintuple Aim
Positive Sentiment: Wall Street commentary remains moderately optimistic, with analysts still bullish on Intuitive Surgical’s long-term prospects despite recent underperformance versus the broader market. Are Wall Street Analysts Bullish on Intuitive Surgical Stock?
Neutral Sentiment: Investor interest continues around the SP platform, where strong procedure growth suggests an important future opportunity, but it remains unclear whether this is true addressable-market expansion or mostly a shift within existing robotic procedures. ISRG’s SP Platform: Early-Stage Growth or Next TAM Expansion Driver?
Neutral Sentiment: There was also minor insider selling by an executive, but the transactions were very small and made under a pre-arranged 10b5-1 plan, so the signal for investors is limited. Mark Brosius insider transaction
Negative Sentiment: The stock has also been hurt by recent weakness after earnings, with market commentary noting a roughly 7% decline since the last report, reflecting concern that the shares may need more proof of sustained acceleration. Why Is Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report?
Negative Sentiment: Several articles also point out that ISRG has significantly lagged the market over the past six months, which may be keeping valuation-sensitive investors on the sidelines. 3 Big Reasons ISRG Should Be On Your Watchlist

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $446.95, for a total value of $178,780.00. Following the sale, the executive vice president owned 6,120 shares of the company’s stock, valued at $2,735,334. This trade represents a 6.13% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 5,701 shares of company stock valued at $2,783,807 in the last three months. Insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Argus decreased their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. TD Cowen decreased their price objective on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Evercore decreased their price objective on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a report on Monday, April 6th. Piper Sandler decreased their price objective on Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Finally, Robert W. Baird boosted their price objective on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $579.33.

View Our Latest Stock Report on Intuitive Surgical

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $438.10 on Monday. The stock has a fifty day simple moving average of $458.62 and a 200 day simple moving average of $510.37. Intuitive Surgical, Inc. has a 12-month low of $417.74 and a 12-month high of $603.88. The company has a market capitalization of $155.16 billion, a P/E ratio of 53.10, a price-to-earnings-growth ratio of 3.50 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the prior year, the company posted $1.81 earnings per share. Intuitive Surgical’s revenue was up 23.0% compared to the same quarter last year. On average, analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.